Company: APM
Filing Date: 2025-12-05
Form Type: 424B5
Source: 0001213900-25-118752
Chunk: 42

Company: Aptorum Group Ltd
Filing Date: 2025-12-05
Form: 424B5
Chunk 42
---
. |

| ● | Risks related to some Aptorum and DiamiR officers and directors having interests in the Merger that are different from yours and that may influence them to support or approve the Merger without regard to your interests. |

<div align='center'>16</div>

| ● | Risks related to the possibility that market price of the combined company’s shares may decline as a result of the Merger. |

| ● | Risks related to Aptorum and DiamiR shareholders not realizing a benefit from the Merger commensurate with the ownership dilution they will experience in connection with the Merger. |

| ● | Risks related to Aptorum and DiamiR being prohibited from seeking out alternative business combinations before the Merger is complete, especially if it is never consummated. |

| ● | Risks related to management of the Combined Company. |

| ● | Because DiamiR has yet to generate revenue from product sales on which to evaluate its potential for future success and to determine if DiamiR will be able to execute its business plan, it is difficult to evaluate DiamiR’s prospects and the likelihood of success or failure of its business. |

Risks Related to Doing Business in Hong Kong

| ● | Risks relating to legal and regulatory risks associated with our operations in Hong Kong.                                                                                                                                                                                                                                                                                                                                |
| ● | If we become directly subject to the recent scrutiny, criticism and negative publicity involving U.S.-listed Chinese companies, we may have to expend significant resources to investigate and resolve the matter which could harm our business operations, stock price and reputation and could result in a loss of your investment in our stock, especially if such matter cannot be addressed and resolved favorably. |
| ● | The recent joint statement by the SEC, proposed rule changes submitted by Nasdaq, and an act passed by the U.S. Senate and the U.S. House of Representatives, all call for additional and more stringent criteria to be applied to emerging market companies. These developments could add uncertainties to our offering, business operations, share price and reputation.                                               |
| ● | Our business, financial condition and results of operations, and/or the value of our Class A Ordinary Shares or our ability to offer or continue to offer securities to investors may be materially and adversely affected to the extent the laws and regulations of the PRC become applicable to a company such as us.                                                                                                  |

<div align='center'>17</div>

| ● | The uncertainties with respect to the Chinese legal system, including uncertainties regarding